An exploratory clinical trial of preoperative non-invasive localization before breast-conserving surgery using augmented reality technology
Open Access
- 14 May 2024
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 206 (1) , 31-44
Abstract
Purpose: This single-center, randomized, prospective, exploratory clinical trial was conducted to assess the clinical efficacy of an augmented reality (AR)—based breast cancer localization imaging solution for patients with breast cancer. Methods: This clinical trial enrolled 20 women who were diagnosed with invasive breast cancer between the ages of 19 and 80, had a single lesion with a diameter ≥ 5 mm but ≤ 30 mm, had no metastases to other organs, and had not received prior chemotherapy. All patients underwent mammography, ultrasound, computed tomography, and magnetic resonance imaging for preoperative assessment. Patients were randomly assigned to ultrasound-guided skin marking localization (USL) and AR-based localization (ARL) groups (n = 10 in each group). Statistical comparisons between USL and ARL groups were made based on demographics, radiologic features, pathological outcomes, and surgical outcomes using chi-square and Student t-tests. Results: Two surgeons performed breast-conserving surgery on 20 patients. Histopathologic evaluation of all patients confirmed negative margins. Two independent pathologists evaluated the marginal distances, and there were no intergroup differences in the readers' estimates (R1, 6.20 ± 4.37 vs. 5.04 ± 3.47, P = 0.519; R2, 5.10 ± 4.31 vs. 4.10 ± 2.38, P = 0.970) or the readers' average values (5.65 ± 4.19 vs. 4.57 ± 2.84, P = 0.509). In comparing the tumor plane area ratio, there was no statistically significant difference between the two groups in terms of either reader's mean values (R1, 15.90 ± 9.52 vs. 19.38 ± 14.05, P = 0.525; R2, 15.32 ± 9.48 vs. 20.83 ± 12.85, P = 0.290) or the overall mean values of two readers combined (15.56 ± 9.11 vs. 20.09 ± 13.38, P = 0.388). Convenience, safety, satisfaction, and reusability were all superior in the AR localization group (P < 0.001) based on the two surgeons' responses. Conclusion: AR localization is an acceptable alternative to ultrasound-guided skin marking with no significant differences in surgical outcomes.Keywords
Funding Information
- SKIA
This publication has 22 references indexed in Scilit:
- Breast cancer surgery with augmented realityThe Breast, 2021
- A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancersBreast Cancer Research and Treatment, 2020
- Ultrasound-Guided Versus Wire-Guided Breast-Conserving Surgery for Nonpalpable Breast CancerClinical Breast Cancer, 2016
- 3D surface imaging of the human female torso in upright to supine positionsMedical Engineering & Physics, 2015
- A comparison of three methods for non-palpable breast cancer excisionEuropean Journal of Surgical Oncology, 2012
- Radioguided occult lesion localization plus sentinel node biopsy (SNOLL) versus wire-guided localization plus sentinel node detection: A case control study of 129 unifocal pure invasive non-palpable breast cancersEuropean Journal of Surgical Oncology, 2012
- Comparison of radioguided occult lesion localization (ROLL) and wire localization for non‐palpable breast cancers: A meta‐analysisJournal of Surgical Oncology, 2011
- Surgical benefits conveyed by biopsy site marking system using ultrasound localizationThe American Journal of Surgery, 2005
- Surgical margins in patients with early-stage breast cancer treated with breast conservation therapyThe American Journal of Surgery, 2002
- Effect of reexcision on the success of breast-conserving surgeryAnnals of Surgical Oncology, 1995